CD79A and infection: Furthermore, SARS-CoV-2 antigen–specific IgG and IgA antibodies have been detected up to 12 months after infection in people without HIV-1 (PWOH), indicating that robust and durable antibody titers can be generated to these viral antigens (8, 9).